BDB Pitmans has acted for SourceBio International Plc on its successful admission to trading and on a placing as part of the IPO.
SourceBio is a leading international provider of integrated state-of-the-art laboratory services and products for the healthcare, clinical, life science research and biopharma industries, with a focus on improving patient diagnosis management and care. SourceBio’s core business areas include healthcare diagnostics, genomics, stability storage and infectious disease testing.
Nick McCarthy (Picture), corporate partner at BDB Pitmans led on the deal with Andrew McGlashan, legal director. Nick and Andrew were assisted by corporate partners Philip Lamb and Hollie Gallagher together with legal director Toby Richards-Carpenter, senior associate Rebecca Arnheim, associate Michelle Gorman, and solicitors Daniela Munro and Ashley Robertson.
Involved fees earner: Rebecca Arnheim – BDB Pitmans LLP; Hollie Gallagher – BDB Pitmans LLP; Michelle Gorman – BDB Pitmans LLP; Philip Lamb – BDB Pitmans LLP; Nick McCarthy – BDB Pitmans LLP; Andrew McGlashan – BDB Pitmans LLP; Daniela Munro – BDB Pitmans LLP; Toby Richards-Carpenter – BDB Pitmans LLP; Ashley Robertson – BDB Pitmans LLP;
Law Firms: BDB Pitmans LLP;
Clients: SourceBio International Plc;